Overview
Job Description:
Dendreon Pharmaceuticals is seeking a Public Health Analyst to join our remote team. The ideal candidate will have a strong background in public health research and analysis, with experience interpreting data to support policy development and health initiatives. This role offers flexibility in working hours and provides an opportunity to contribute to impactful public health projects from anywhere in the United States.
Responsibilities:
Collect, clean, and analyze public health data to identify trends and issues.
Prepare reports, presentations, and visualizations to communicate findings to stakeholders.
Support public health program evaluations by designing and implementing data collection methods.
Collaborate with internal teams and external partners to provide data-driven insights that inform policy and decision-making.
Monitor public health trends and conduct impact assessments for ongoing programs and initiatives.
Contribute to the development of health promotion strategies based on evidence from data analysis.
Provide recommendations for improving public health programs based on research and analysis.
Key Skills & Qualifications:
Bachelor’s or Master’s degree in Public Health, Epidemiology, Statistics, or related field.
1+ years of experience in public health data analysis or related work.
Strong proficiency with statistical software (e.g., SAS, SPSS, R, or Python).
Experience in analyzing large datasets and generating meaningful insights.
Excellent written and verbal communication skills, with the ability to present complex information in a clear and actionable manner.
Strong attention to detail and ability to manage multiple projects simultaneously.
Ability to work independently in a remote environment with flexible hours.
Knowledge of health policy, epidemiology, and public health systems is a plus.
Benefits:
Competitive hourly rate of $48/hr.
Flexible working hours to accommodate work-life balance.
Opportunity to work remotely from anywhere in the United States.
Collaborative, inclusive, and supportive team culture.
Professional development opportunities.
About Dendreon Pharmaceuticals
Dendreon is a commercial-stage biopharmaceutical company and end-to-end provider of manufacturing services for the cell therapy market. Founded on the belief that immunotherapy made from a patient’s own cells will transform disease treatment, Dendreon has worked tirelessly to make the fight against cancer personal.
Our flagship product, PROVENGE (sipuleucel-T), was the first FDA-approved immunotherapy to harness the innate benefits of personalized cellular treatment made from a patient’s own immune cells.
Since its FDA-approval in 2010, nearly 40,000 men have been prescribed PROVENGE. Now Dendreon is helping to advance other cell therapies from clinic to market by leveraging the extensive experience of developing and commercializing PROVENGE.
Dendreon paved the way as the first FDA-approved cell therapy made from a patient’s own immune cells. Prior to the development of PROVENGE, there was no roadmap for how to establish and monitor critical process parameters, or the potency and stability of cellular therapeutics. Our work established such processes. Building on our achievements, we are now working with partners to provide the end-to-end manufacturing services and regulatory expertise needed to commercialize new treatments. Our hope is that by pushing research forward, we may change the lives of patients and their families.
